Stock detail
Incyte (INCY) stock price, chart, and key data
View Incyte stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Incyte
INCY · XNAS
$112.79
+0.04%
+$0.04
Overnight $113.41 (+0.55%)
Key metrics
52-week range
$7.75 - $3.00
Close price
$112.75
Market cap
$22.9B
P/E ratio
14.36
Beta
0.63
About the company
Incyte Genomics Inc
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$133
11
Buy
/ 21
Recent calls
10/09/2026
Bank of America Securities
Tazeen Ahmad
Buy · Price target $140
10/08/2026
RBC Capital
Brian Abrahams
Hold · Price target $114
10/05/2026
H.C. Wainwright
Mitchell Kapoor
Buy · Price target $152
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app